Dr. Huda Zoghbi awarded 2nd Elaine Redding Brinster Prize in Science or Medicine
Dr. Huda Zoghbi,director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, a distinguished service professor at Baylor College of Medicine and an investigator with Howard Hughes Medical Institute, has beenawarded the second Elaine Redding Brinster Prize in Science or Medicine from the Penn Institute for Regenerative Medicine at the University of Pennsylvania.
She is being recognized for her work pinpointing the underlying, genetic causes of a pair of devastating neurological diseases. Her work has advanced the field’s conceptual understanding of how gene expression can influence neurological health, even in non-inherited disorders.
"I am deeply honored and humbled to be recognized by the Elaine Redding Brinster Prize for research that was inspired by my patients," said Zoghbi. "For me, it is also very special to be part of the Ralph Brinster Symposium as my research benefited immensely from technologies developed by Professor Brinster.”
The prize, supported by an endowment from the children of Elaine Redding Brinster, is awarded annually to a researcher whose singular discovery has made a unique impact on biomedicine. Each winner receives $100,000, a commemorative medal, and an invitation to present a ceremonial lecture at the University of Pennsylvania.
"Dr. Zoghbi’s interests in the basis for neurological disorders were sparked by her initial observations in the clinic," said Dr. Ken Zaret, director of the Institute for Regenerative Medicine and the Joseph Leidy Professor of Cell and Developmental Biology. "It was an exceptional path from there to revealing how mutations in a methyl-DNA binding protein cause Rett syndrome and how expansion of DNA repeat sequences cause spinocereballar ataxia 1.”
Zoghbi will accept the prize March 15, 2023, as part of the day-long Ralph L. Brinster Symposium. The symposium will feature several eminent speakers from across the biomedical sciences, including Janet Rossant, PhD, of the University of Toronto, Lynne Maquat, PhD, of the University of Rochester, Karl Deisseroth, MD, PhD, of Stanford University, and Lorenz Studer, MD, of Memorial-Sloan Kettering.
Zoghbi’s work also focuses on pursuing the genetic basis of Rett syndrome, a rare and sporadic neurological and developmental disorder that affects the way the brain functions after birth, causing a progressive loss of motor skills and language, primarily in female patients.
Previously, Zoghbi won several prestigious awards, including the Kavli Prize for Neuroscience, the Breakthrough Prize, the Gairdner International Award, and the March of Dimes Prize in Developmental Biology. Zogbhi is a member of the U.S. National Academy of Medicine and National Academy of Sciences.